Weight gain and ethnic background as determinants of HbA1c 11-years after pregnancy: the STORK-Groruddalen follow-up study

被引：0
|
作者：
Waage, C. [1 ]
Sommer, C. [2 ]
Mdala, I. [1 ]
Lee-Odegard, S. [2 ,3 ]
Braend, A. M. [1 ]
Jenum, A. K. [1 ]
Birkeland, K. I. [2 ,3 ]
机构：
[1] Univ Oslo, Inst Hlth & Soc, Dept Gen Practice, Fac Med, Oslo, Norway
[2] Oslo Univ Hosp, Dept Endocrinol Morbid Obes & Prevent Med, Oslo, Norway
[3] Univ Oslo, Inst Clin Med, Fac Med, Oslo, Norway
来源：
DIABETOLOGIA | 2024年 / 67卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
373
引用
收藏
页码：S189 / S189
页数：1
相关论文
共 50 条
  • [21] Achieving the Composite End Point of HbA1c <7%, No Hypos, and No Weight Gain: Comparison between Vildagliptin and Glimepiride after 2 Years of Treatment
    Ferrannini, Ele
    Bader, Giovanni
    Ahren, Bo
    Fonseca, Vivian
    Zinman, Bernard
    Matthews, David
    DIABETES, 2011, 60 : A279 - A279
  • [22] Impact of change in HbA1c on nerve conduction and muscle function parameters in type 1 diabetes: a 1 year follow-up study from India
    Desai, K.
    Mondkar, S.
    Karguppikar, M.
    Oza, C.
    Borse, S.
    Khadilkar, V.
    Khadilkar, A.
    HORMONE RESEARCH IN PAEDIATRICS, 2024, 97 : 188 - 189
  • [23] BILIO-PANCREATIC LIMB LENGTH AND CHANGE IN HBA1C IN DIABETIC PATIENTS AFTER MGB-OAGB, A 14 YEARS FOLLOW UP
    Kular, K. S.
    OBESITY SURGERY, 2023, 33 : 55 - 55
  • [24] Achieving the composite end point of HbA1c <7%, no hypos, and no weight gain: comparison between vildagliptin and glimepiride after 2 years of treatment
    Bader, G.
    Ferrannini, E.
    Bo, A.
    Fonseca, V.
    Zinman, B.
    Matthews, D.
    DIABETOLOGIA, 2011, 54 : S339 - S340
  • [25] Association of HbA1c and Peripheral Neuropathy in a Ten-Year Follow-up Study of Healthy, Prediabetic and Type 2 Diabetic Individuals
    Peterson, Magnus
    Pingel, Ronnie
    Lagali, Neil
    Dahlin, Lars
    Rolandson, Olov
    DIABETES, 2016, 65 : A150 - A150
  • [26] Vildagliptin more effectively achieves a composite endpoint of HbA1c < 7.0% without hypoglycaemia and weight gain compared with glimepiride after 2 years of treatment
    Bader, Giovanni
    Geransar, Parnia
    Schweizer, Anja
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2013, 100 (03) : E78 - E81
  • [27] A follow-up study of the occurrence and consequences of HbA1c measurements in an unselected cohort of non-pharmacologically treated patients with Type 2 diabetes
    Kristensen, Jette Kolding
    Stoevring, Henrik
    SCANDINAVIAN JOURNAL OF PRIMARY HEALTH CARE, 2008, 26 (01) : 57 - 62
  • [28] Diabetes knowledge predicts HbA1c levels of people with type 2 diabetes mellitus in rural China: a ten-month follow-up study
    Xiaoying Wang
    Bo Tian
    Shengfa Zhang
    Jinsui Zhang
    Weiping Yang
    Jina Li
    Weiwei Wang
    Yuchen Wang
    Weijun Zhang
    Scientific Reports, 13
  • [29] Diabetes knowledge predicts HbA1c levels of people with type 2 diabetes mellitus in rural China: a ten-month follow-up study
    Wang, Xiaoying
    Tian, Bo
    Zhang, Shengfa
    Zhang, Jinsui
    Yang, Weiping
    Li, Jina
    Wang, Weiwei
    Wang, Yuchen
    Zhang, Weijun
    SCIENTIFIC REPORTS, 2023, 13 (01)
  • [30] Increased risk of adverse cardiovascular events by strict glycemic control after percutaneous coronary intervention (HbA1c < 6.5% at 2 years) in type 2 diabetes mellitus combined with acute coronary syndrome: a 5-years follow-up study
    Yang, Tiangui
    Fu, Peng
    Chen, Jie
    Fu, Xi
    Xu, Changlu
    Liu, Xiaoxia
    Niu, Tiesheng
    CURRENT MEDICAL RESEARCH AND OPINION, 2021, 37 (09) : 1517 - 1528
12345